Novamind has announced it has been selected by MindMed to host a phase IIb randomized clinical trial investigating LSD for generalized anxiety disorder (GAD) in adults (“LSD Clinical Trial”).
Category Press Release
Published in Novamind
Companies Featured
NovamindNovamind has bold plans for building out a psychedelic ecosystem. One that spans from ketamine-assisted psychotherapy and psilocybin retreats to novel clinical trials.
MindMed
MindMed is one of the largest companies in the psychedelics space and is developing various psychedelics for mental health disorders.